Predicting treatment outcome following 24 weeks peginterferon α-2a/ribavirin therapy in patients infected with HCV genotype 1: Utility of HCV-RNA at Day 0, Day 22, Day 29, and Week 6 [3] / Lukasiewicz, Esther; Hellstrand, Kristoffer; Westin, Johan; Ferrari, Carlo; Neumann, Avidan U.; Pawlotsky, Jean Michel; Schalm, Solko W.; Zeuzem, Stefan; Veldt, Bart J.; Hansen, Bettina E.; Verhey Hart, Elke; Lagging, Martin. - In: HEPATOLOGY. - ISSN 0270-9139. - 45:1(2007), pp. 258-259. [10.1002/hep.21505]

Predicting treatment outcome following 24 weeks peginterferon α-2a/ribavirin therapy in patients infected with HCV genotype 1: Utility of HCV-RNA at Day 0, Day 22, Day 29, and Week 6 [3]

FERRARI, Carlo;
2007-01-01

2007
Predicting treatment outcome following 24 weeks peginterferon α-2a/ribavirin therapy in patients infected with HCV genotype 1: Utility of HCV-RNA at Day 0, Day 22, Day 29, and Week 6 [3] / Lukasiewicz, Esther; Hellstrand, Kristoffer; Westin, Johan; Ferrari, Carlo; Neumann, Avidan U.; Pawlotsky, Jean Michel; Schalm, Solko W.; Zeuzem, Stefan; Veldt, Bart J.; Hansen, Bettina E.; Verhey Hart, Elke; Lagging, Martin. - In: HEPATOLOGY. - ISSN 0270-9139. - 45:1(2007), pp. 258-259. [10.1002/hep.21505]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2814927
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 6
social impact